BABA vs HAS

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

HAS exhibits a critical disconnect between strong top-line growth and deteriorating financial health, evidenced by a weak Piotroski F-Score of 2/9. While revenue growth is impressive at 31.3% and operating margins remain healthy, the company is burdened by an extreme Debt/Equity ratio of 6.01 and negative ROE. Insider activity is heavily bearish with significant selling by the CEO and CFO. The dividend is precarious with a 92.41% payout ratio, suggesting limited room for error despite analyst optimism.